DURECT Corporation - stock earnings
DRRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -3.0 million USD | 1.7 million USD |
| 2023Q2 | -11.2 million USD | 2.1 million USD |
| 2023Q1 | -12.2 million USD | 2.1 million USD |
| 2022Q4 | -9.4 million USD | 3.3 million USD |
| 2022Q3 | -2.8 million USD | 12.0 million USD |
| 2022Q2 | -12.0 million USD | 2.1 million USD |
| 2022Q1 | -11.3 million USD | 1.9 million USD |
| 2021Q4 | -7.0 million USD | 7.3 million USD |
| 2021Q3 | -10.0 million USD | 2.2 million USD |
| 2021Q2 | -9.1 million USD | 2.3 million USD |
| 2021Q1 | -10.1 million USD | 2.2 million USD |
| 2020Q4 | 4.4 million USD | 2.2 million USD |
| 2020Q3 | -9.3 million USD | 2.7 million USD |
| 2020Q2 | 14.3 million USD | 25.8 million USD |
| 2020Q1 | -9.9 million USD | 2.8 million USD |
| 2019Q4 | -4.2 million USD | 10.7 million USD |
| 2019Q3 | -2.0 million USD | 10.8 million USD |
| 2019Q2 | -7.2 million USD | 4.0 million USD |
| 2019Q1 | -7.1 million USD | 4.1 million USD |
| 2018Q4 | -7.3 million USD | 3.6 million USD |
| 2018Q3 | -2.7 million USD | 8.0 million USD |
| 2018Q2 | -7.0 million USD | 3.4 million USD |
| 2018Q1 | -8.3 million USD | 3.5 million USD |
| 2017Q4 | 8.2 million USD | 19.5 million USD |
| 2017Q3 | 6.1 million USD | 20.7 million USD |
| 2017Q2 | -9.9 million USD | 4.3 million USD |
| 2017Q1 | -8.1 million USD | 4.6 million USD |
| 2016Q4 | -8.8 million USD | 3.5 million USD |
| 2016Q3 | -8.8 million USD | 3.7 million USD |
| 2016Q2 | -9.0 million USD | 3.2 million USD |
| 2016Q1 | -7.9 million USD | 3.6 million USD |
| 2015Q4 | -5.8 million USD | 5.2 million USD |
| 2015Q3 | -6.5 million USD | 4.7 million USD |
| 2015Q2 | -5.5 million USD | 4.4 million USD |
| 2015Q1 | -4.9 million USD | 4.8 million USD |
| 2014Q4 | -5.9 million USD | 4.3 million USD |
| 2014Q3 | -7.1 million USD | 4.3 million USD |
| 2014Q2 | -5.5 million USD | 4.6 million USD |
| 2014Q1 | -3.6 million USD | 6.3 million USD |
| 2013Q4 | -5.1 million USD | 4.3 million USD |
| 2013Q3 | -6.0 million USD | 3.0 million USD |
| 2013Q2 | -5.1 million USD | 3.9 million USD |
| 2013Q1 | -5.2 million USD | 4.2 million USD |
| 2012Q4 | -5.5 million USD | 3.3 million USD |
| 2012Q3 | -4.8 million USD | 3.8 million USD |
| 2012Q2 | -4.3 million USD | 4.8 million USD |
| 2012Q1 | 30.8 million USD | 41.2 million USD |
| 2011Q4 | -2.1 million USD | 8.9 million USD |
| 2011Q3 | -5.0 million USD | 8.1 million USD |
| 2011Q2 | -5.2 million USD | 7.8 million USD |
| 2011Q1 | -6.4 million USD | 8.6 million USD |
| 2010Q4 | -5.3 million USD | 8.5 million USD |
| 2010Q3 | -4.6 million USD | 8.1 million USD |
| 2010Q2 | -6.3 million USD | 7.3 million USD |
| 2010Q1 | -6.6 million USD | 7.7 million USD |
| 2009Q4 | -8.6 million USD | 4.9 million USD |
| 2009Q3 | -5.5 million USD | 8.4 million USD |
| 2009Q2 | -7.5 million USD | 4.9 million USD |
| 2009Q1 | -8.7 million USD | 6.2 million USD |
| 2008Q4 | -18.4 million USD | 7.7 million USD |
| 2008Q3 | -9.2 million USD | 6.6 million USD |
| 2008Q2 | -8.6 million USD | 6.3 million USD |
| 2008Q1 | -7.8 million USD | 6.4 million USD |
| 2007Q4 | -7.2 million USD | 6.6 million USD |
| 2007Q3 | -7.9 million USD | 4.9 million USD |
| 2007Q2 | -479000 USD | 13.4 million USD |
| 2007Q1 | -8.8 million USD | 5.7 million USD |
| 2006Q4 | -9.8 million USD | 5.4 million USD |
| 2006Q3 | -8.6 million USD | 5.1 million USD |
| 2006Q2 | -8.7 million USD | 6.1 million USD |
| 2006Q1 | -6.3 million USD | 5.2 million USD |
| 2005Q4 | -6.0 million USD | 5.8 million USD |
| 2005Q3 | -3.0 million USD | 8.6 million USD |
| 2005Q2 | -3.6 million USD | 8.8 million USD |
| 2005Q1 | -5.4 million USD | 5.4 million USD |
| 2004Q4 | -7.0 million USD | 4.0 million USD |
| 2004Q3 | -7.3 million USD | 3.4 million USD |
| 2004Q2 | -7.4 million USD | 3.1 million USD |
| 2004Q1 | -6.0 million USD | 3.4 million USD |
| 2003Q4 | -5.3 million USD | 3.1 million USD |
| 2003Q3 | -6.4 million USD | 3.0 million USD |
| 2003Q2 | -5.1 million USD | 3.2 million USD |
| 2003Q1 | -5.9 million USD | 2.6 million USD |
| 2002Q4 | -8.5 million USD | 2.0 million USD |
| 2002Q3 | -9.1 million USD | 1.8 million USD |
| 2002Q2 | -9.9 million USD | 1.8 million USD |
| 2002Q1 | -9.7 million USD | 1.6 million USD |
| 2001Q4 | -10.1 million USD | 1.6 million USD |
| 2001Q3 | -8.9 million USD | 1.8 million USD |
| 2001Q2 | -21.0 million USD | 1.7 million USD |
| 2001Q1 | -4.9 million USD | 1.4 million USD |
| 2000Q4 | -4.9 million USD | 973000 USD |
| 2000Q3 | -5.7 million USD | 1.1 million USD |
| 2000Q2 | -4.6 million USD | 541000 USD |
| 2000Q1 | -4.6 million USD | 541000 USD |
DRRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -36.7 million USD | 9.2 million USD |
| 2022 | -35.6 million USD | 19.3 million USD |
| 2021 | -38.1 million USD | 14.0 million USD |
| 2020 | -2.5 million USD | 30.1 million USD |
| 2019 | -22.8 million USD | 29.6 million USD |
| 2018 | -25.3 million USD | 18.6 million USD |
| 2017 | -3.7 million USD | 49.2 million USD |
| 2016 | -34.5 million USD | 14.0 million USD |
| 2015 | -22.7 million USD | 19.1 million USD |
| 2014 | -22.1 million USD | 19.4 million USD |
| 2013 | -21.5 million USD | 15.3 million USD |
| 2012 | 16.2 million USD | 53.1 million USD |
| 2011 | -18.8 million USD | 33.5 million USD |
| 2010 | -22.9 million USD | 31.6 million USD |
| 2009 | -30.7 million USD | 24.3 million USD |
| 2008 | -45.1 million USD | 26.0 million USD |
| 2007 | -24.3 million USD | 30.7 million USD |
| 2006 | -33.3 million USD | 21.9 million USD |
| 2005 | -18.1 million USD | 28.6 million USD |
| 2004 | -27.6 million USD | 13.9 million USD |
| 2003 | -22.7 million USD | 11.8 million USD |
| 2002 | -37.2 million USD | 7.2 million USD |
| 2001 | -44.9 million USD | 6.5 million USD |
| 2000 | -19.9 million USD | 3.2 million USD |
| 1999 | -8.7 million USD | 86000 USD |
DRRX
Price: $0.99
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.20 USD
P/E Ratio: -0.55
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 37400
Ebitda: 6.8 millionMarket Capitalization: 25.5 million